Wednesday, Jul 29, 2026 · SEC filings
What the smart money revealed on Jul 29
298 insider filings came in. We hid 54 planned (10b5-1) sellers and 192 people whose filings were routine, like grants and tax withholding.
Scribe Therapeutics (SCTX) Director Carl Gordon bought $15M
1M shares on the open market. Not a grant or an option exercise. Their past buys: 2 of 3 checked quarters beat the typical stock 6 months later.
Betterware de Mexico, S.A.P.I. de C.V (BWMX) Director Luis Campos bought $768K
46,830 shares on the open market. Not a grant or an option exercise.
Outlook Therapeutics (OTLK) Director Faisal Sukhtian bought $100K
95,398 shares on the open market. Not a grant or an option exercise.
Equity Bancshares (EQBK) Director Lisa Schlehuber bought $50.4K
989 shares on the open market. Not a grant or an option exercise.
Parnassus Investments filed its holdings: 135 stocks
Holdings as of Jun 30, 2026. Open the fund to see what it bought and sold.
Mastercard Foundation Asset Management filed its holdings: 3 stocks
Holdings as of Jun 30, 2026. Open the fund to see what it bought and sold.
Charles Schwab (SCHW) Co-Chairman Walter Bettinger sold $29.8M
Not marked as a planned 10b5-1 sale. Sold 35% of the shares they held directly. Still holds 529,346 shares.
Bancfirst (BANF) Director David Rainbolt sold $11M
Not marked as a planned 10b5-1 sale. Sold 69% of the shares they held directly. Still holds 42,833 shares.
Honeywell International (HON) Pres/CEO Process Technologies Kenneth West sold $4.15M
Not marked as a planned 10b5-1 sale. Sold 89% of the shares they held directly. Still holds 2,132 shares.
13F season
Holdings as of Jun 30, 2026 are due Aug 14
8,899 funds have filed so far. 8,900 filed for the quarter before.
Biggest real insider buys this week
Open-market buys by officers and directors, filed in the 7 days up to Jul 29.
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.